Data Fragmentation
Models trained on siloed, context-poor data produce unreliable results. Without standardized, traceable data from every instrument, AI initiatives start blind and stay blind.
For Data & AI Leaders
AI-Ready Scientific Data with Full Provenance and Context
The gap between AI ambition and data infrastructure readiness is the defining challenge for pharma R&D. ZONTAL provides the validated data foundation that makes AI work — standardized, contextualized, and traceable from instrument to model.
Trusted by 6 of the 10 largest pharmaceutical companies in the world
And leading biotechs and agrochemical companies
6 of 10
Top-10 Pharma Companies
150+
Vendors
400+
Instrument Models
100+
Analytical Techniques
The Data Foundation
What AI-Ready Data Requires
77% of life sciences labs expect to use AI within two years. AI remains the top investment area at 63% (Pistoia Alliance 2024). But only 11% of biopharma labs have reached a fully predictive state (Deloitte 2024). Here’s what the remaining 89% need to build first.
Governance Gap
No audit trail from model input to decision. In regulated pharma, AI without traceability and governance cannot reach production - no matter how accurate the model.
No Compounding
Each AI initiative starts from scratch - new data pipelines, new validation, new integrations. Without a shared foundation, the organization never builds cumulative data assets.
The ICAD Path to AI
AI Is the Decide Principle. You Can't Skip Integrate, Contextualize, Analyze.
Each principle creates the data asset that the next principle consumes. Skip a principle, and you're building AI on sand.
I
Integration
Standardized, audit-trailed data from every instrument in your fleet. The raw material that everything else depends on.
C
Context
Complete lineage and scientific context preserved across the data lifecycle. Data without context is noise - context turns it into knowledge.
A
Intelligence
Stability trending, cross-program analysis, and pattern detection at portfolio scale. Insights that no single application can deliver.
D
AI Decisions
Stability intelligence, agentic workflow services, closed-loop automation, and supervised autonomy — built on a validated foundation, not on assumptions.
AI Terminology Done Right
Precision Language for Regulated Science
In pharma, every claim must be defensible. AI terminology should be no different. ZONTAL uses exact language that maps to specific capabilities, governance models, and principles.
Generation Tasks
Converter authoring, document drafting, pattern suggestion. The AI generates options. The scientist validates and decides. Human judgment remains the final authority.
Workflow Orchestration
Multi-step scientific workflows with configurable governance. The system orchestrates complex sequences across instruments and data sources — from fully autonomous routine operations to human-supervised regulated decisions.
Closed-Loop Lab Automation
Instruments, workflows, and models operate within validated boundaries. Routine operations execute autonomously. Regulated decisions and exceptions route to human review based on your configured oversight level.
We say exactly what the AI does, with what governance, and at what level of the infrastructure.
Competitive Advantage
Your Scientific Data Is a Competitive Asset
Every pharma company has unique experimental data, proprietary methods, and institutional knowledge. Most of it is trapped in instrument files, spreadsheets, and disconnected systems. ZONTAL unlocks this data as a strategic asset that compounds over time.
Standardize
Raw instrument data, proprietary formats, and legacy systems - standardized into a standardized, queryable data asset across your entire fleet.
Contextualize
Scientific meaning, experimental lineage, and regulatory context preserved alongside every data point. Context transforms data into knowledge.
Govern
Full audit trail, 21 CFR Part 11 compliance, and data integrity validation. Your data moat is only as strong as its traceability foundation.
When your scientific data is standardized, contextualized, and audit-trailed, it becomes the training data that no competitor can replicate.
Outcomes for Data & AI
Three Starting Points for AI-Ready Infrastructure
Want a custom analysis for your AI data readiness?
Get a tailored Executive Brief with ICAD maturity scoring, AI readiness gap analysis, and a data-to-AI roadmap.
Get the Executive Brief
The Market Data
The Foundation Comes First
77%
Of labs expect AI within 2 years
11%
Of biopharma labs at fully predictive state
63%
AI as top investment area
81%
ELN adoption rate across labs
Sources: Pistoia Alliance 2024, Deloitte 2024. The market data confirms: the foundation comes first. Full autonomy follows.
How to Start
Validate the Architecture
Explore the ICAD Architecture
Probe the four layers — Integration, Context, Intelligence, and AI-Enabled Decisions. Understand the data model, context graphs, and how governed data flows from instrument to insight.
Score Your AI Readiness
A 5-minute diagnostic that scores your organization across the ICAD principles. Identify where your data foundation stands and what needs to happen before AI reaches production.
Book an Architecture Review
30-minute architecture review with your team. We map your data maturity to a phased AI deployment plan — no slides, just infrastructure reality.